| Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects SE Reuter, AM Evans Clinical pharmacokinetics 51 (9), 553-572, 2012 | 467 | 2012 |
| Reliability and validity of indices of hand‐grip strength and endurance SE Reuter, N Massy‐Westropp, AM Evans Australian occupational therapy journal 58 (2), 82-87, 2011 | 88 | 2011 |
| Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease AM Evans, RJ Faull, RL Nation, S Prasad, T Elias, SE Reuter, G Fornasini Kidney international 66 (4), 1527-1534, 2004 | 81 | 2004 |
| Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients SE Reuter, RJ Faull, E Ranieri, AM Evans Nephrology Dialysis Transplantation 24 (3), 990-996, 2009 | 64 | 2009 |
| Determination of the reference range of endogenous plasma carnitines in healthy adults SE Reuter, AM Evans, DH Chace, G Fornasini Annals of clinical biochemistry 45 (6), 585-592, 2008 | 58 | 2008 |
| A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients C Lau, D Marriott, M Gould, D Andresen, SE Reuter, J Penm Journal of Antimicrobial Chemotherapy 75 (3), 718-725, 2020 | 57 | 2020 |
| Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome SE Reuter, JH Martin Clinical pharmacokinetics 55, 807-812, 2016 | 57 | 2016 |
| L‐carnitine supplementation in the dialysis population: Are Australian patients missing out? SE Reuter, RJ Faull, AM Evans Nephrology 13 (1), 3-16, 2008 | 50 | 2008 |
| Long‐chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase‐I activity SE Reuter, AM Evans Journal of internal medicine 270 (1), 76-84, 2011 | 48 | 2011 |
| Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease SE Reuter, AM Evans, RJ Faull, DH Chace, G Fornasini Annals of clinical biochemistry 42 (5), 387-393, 2005 | 39 | 2005 |
| Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology BD Menz, SL Stocker, N Verougstraete, D Kocic, P Galettis, CP Stove, ... British Journal of Clinical Pharmacology 87 (2), 227-236, 2021 | 35 | 2021 |
| Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin SE Reuter, AM Evans, S Shakib, Y Lungershausen, B Francis, G Valentini, ... Clinical drug investigation 35, 559-567, 2015 | 28 | 2015 |
| Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women E Fooladi, SE Reuter, RJ Bell, PJ Robinson, SR Davis Menopause 22 (1), 44-49, 2015 | 28 | 2015 |
| Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure RV Shingde, SE Reuter, GG Graham, JE Carland, KM Williams, RO Day, ... Journal of Antimicrobial Chemotherapy 75 (11), 3293-3302, 2020 | 21 | 2020 |
| Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis SL Stocker, JE Carland, SE Reuter, AE Stacy, AL Schaffer, M Stefani, ... Clinical Pharmacology & Therapeutics 109 (1), 212-221, 2021 | 20 | 2021 |
| Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria SE Reuter, RN Upton, AM Evans, V Navaratnam, PL Olliaro Journal of Antimicrobial Chemotherapy 70 (3), 868-876, 2015 | 19 | 2015 |
| Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer CJ Lucas, P Galettis, S Song, N Solowij, SE Reuter, J Schneider, ... Clinical therapeutics 40 (9), 1442-1447, 2018 | 16 | 2018 |
| Comparison of the area under the curve for vancomycin estimated using compartmental and noncompartmental methods in adult patients with normal renal function RV Shingde, GG Graham, SE Reuter, JE Carland, RO Day, SL Stocker Therapeutic drug monitoring 41 (6), 726-731, 2019 | 14 | 2019 |
| Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with … P Olliaro, S Ramanathan, M Vaillant, SE Reuter, AM Evans, S Krudsood, ... J Bioequiv Availab 2 (3), 59-66, 2010 | 13 | 2010 |
| Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions SA Roydhouse, JE Carland, DS Debono, MT Baysari, SE Reuter, ... British journal of clinical pharmacology 87 (11), 4273-4282, 2021 | 12 | 2021 |
